Hyzaar Extra Forte

Losartan potassium and hydrochlorothiazide, the active ingredients in Hyzaar Extra Forte, are an Angiotensin II receptor blocker (ARB) and a thiazide diuretic presented as a tablet for oral use. They work together to lower blood pressure by relaxing blood vessels and reducing fluid volume, providing effective control of hypertension in adult patients.

GNH USA supplies Hyzaar Extra Forte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Hyzaar Extra Forte combines an ARB and a thiazide diuretic to manage high blood pressure.

Essential hypertension: lowers systolic and diastolic pressure to target levels. Secondary hypertension: provides additional blood pressure control when underlying causes are present. Hypertension in patients requiring combination therapy: offers dual mechanism to improve efficacy.

Hyzaar Extra Forte may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Dizziness or light‑headedness - Headache - Increased urination - Electrolyte disturbances such as low potassium

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Acute kidney injury - Hyperkalemia or severe electrolyte imbalance

Before prescribing Hyzaar Extra Forte, clinicians should consider several precautionary measures.

- Monitor blood pressure: ensure adequate control and avoid hypotension. - Assess renal function: check serum creatinine and eGFR regularly. - Check electrolytes: particularly potassium and sodium levels. - Use cautiously in patients with hepatic impairment: dose adjustment may be required. - Pregnancy and lactation: avoid use unless benefits outweigh risks. - Store at ambient temperature: keep in original packaging, protect from moisture.

Hyzaar Extra Forte can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Potassium‑sparing diuretics or supplements: may cause dangerous hyperkalemia. - ACE inhibitors or aliskiren in diabetic patients: increase risk of renal impairment and hyperkalemia.

Moderate Interactions (Monitor Closely): - NSAIDs: can reduce antihypertensive effect and affect kidney function. - Lithium: may increase lithium levels leading to toxicity. - Antidiabetic agents: blood glucose may drop, requiring dose adjustment.